Ekadharma International (Indonesia) Performance
| EKAD Stock | IDR 218.00 2.00 0.91% |
The firm shows a Beta (market volatility) of 0.058, which means not very significant fluctuations relative to the market. As returns on the market increase, Ekadharma International's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ekadharma International is expected to be smaller as well. At this point, Ekadharma International has a negative expected return of -0.12%. Please make sure to confirm Ekadharma International's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Ekadharma International performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ekadharma International Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
| Total Cashflows From Investing Activities | -13.8 B |
Ekadharma |
Ekadharma International Relative Risk vs. Return Landscape
If you would invest 23,600 in Ekadharma International Tbk on September 17, 2024 and sell it today you would lose (1,800) from holding Ekadharma International Tbk or give up 7.63% of portfolio value over 90 days. Ekadharma International Tbk is generating negative expected returns and assumes 0.8885% volatility on return distribution over the 90 days horizon. Simply put, 7% of stocks are less volatile than Ekadharma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ekadharma International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ekadharma International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ekadharma International Tbk, and traders can use it to determine the average amount a Ekadharma International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1351
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EKAD |
Estimated Market Risk
| 0.89 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ekadharma International is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ekadharma International by adding Ekadharma International to a well-diversified portfolio.
Ekadharma International Fundamentals Growth
Ekadharma Stock prices reflect investors' perceptions of the future prospects and financial health of Ekadharma International, and Ekadharma International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ekadharma Stock performance.
| Return On Equity | 0.0887 | |||
| Return On Asset | 0.0609 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 703.3 B | |||
| Shares Outstanding | 3.49 B | |||
| Price To Earning | 2.58 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 629.88 B | |||
| EBITDA | 128.85 B | |||
| Cash And Equivalents | 360.66 B | |||
| Cash Per Share | 107.95 X | |||
| Total Debt | 19.45 B | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 292.96 X | |||
| Cash Flow From Operations | 45.43 B | |||
| Earnings Per Share | 146.27 X | |||
| Total Asset | 1.17 T | |||
About Ekadharma International Performance
By examining Ekadharma International's fundamental ratios, stakeholders can obtain critical insights into Ekadharma International's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Ekadharma International is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia. PT Ekadharma International Tbk is a subsidiary of PT Ekadharma Inti Perkasa. Ekadharma International operates under Specialty Chemicals classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 587 people.Things to note about Ekadharma International performance evaluation
Checking the ongoing alerts about Ekadharma International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ekadharma International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ekadharma International generated a negative expected return over the last 90 days | |
| About 81.0% of the company shares are held by company insiders |
- Analyzing Ekadharma International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ekadharma International's stock is overvalued or undervalued compared to its peers.
- Examining Ekadharma International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ekadharma International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ekadharma International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ekadharma International's stock. These opinions can provide insight into Ekadharma International's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Ekadharma Stock
Ekadharma International financial ratios help investors to determine whether Ekadharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ekadharma with respect to the benefits of owning Ekadharma International security.